Published in Case Rep Psychiatry on June 18, 2017
The dopamine hypothesis of schizophrenia: version III--the final common pathway. Schizophr Bull (2009) 6.03
Delirium in older people. BMJ (2007) 2.77
British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders. J Psychopharmacol (2010) 1.74
The therapeutic role of 5-HT1A and 5-HT2A receptors in depression. J Psychiatry Neurosci (2004) 1.61
A review of the evidence for the efficacy and safety of trazodone in insomnia. J Clin Psychiatry (2005) 1.57
Risk of Seizures Associated with Antidepressant Use in Patients with Depressive Disorder: Follow-up Study with a Nested Case-Control Analysis Using the Clinical Practice Research Datalink. Drug Saf (2016) 1.44
Visual hallucinations in the psychosis spectrum and comparative information from neurodegenerative disorders and eye disease. Schizophr Bull (2014) 1.32
Visual hallucinations: differential diagnosis and treatment. Prim Care Companion J Clin Psychiatry (2009) 1.20
Trazodone: a review of its pharmacological properties and therapeutic use in depression and anxiety. Drugs (1981) 1.13
The Charles Bonnet syndrome: a review of recent research. Curr Opin Ophthalmol (2006) 1.08
Serotonin (5-HT)2A receptor activation enhances dialysate levels of dopamine and noradrenaline, but not 5-HT, in the frontal cortex of freely-moving rats. Neuropharmacology (1999) 1.05
Factors associated with complex visual hallucinations during antidepressant treatment. Hum Psychopharmacol (2004) 1.04
Pharmacology of hallucinations: several mechanisms for one single symptom? Biomed Res Int (2014) 0.99
Drugs with anticholinergic effects and cognitive impairment, falls and all-cause mortality in older adults: A systematic review and meta-analysis. Br J Clin Pharmacol (2015) 0.98
Elementary visual hallucinations, blindness, and headache in idiopathic occipital epilepsy: differentiation from migraine. J Neurol Neurosurg Psychiatry (1999) 0.97
Hallucinations in bipolar disorder: characteristics and comparison to unipolar depression and schizophrenia. Bipolar Disord (2005) 0.97
Trazodone. A review of its pharmacology, therapeutic use in depression and therapeutic potential in other disorders. Drugs Aging (1994) 0.94
Mechanism of action of trazodone: a multifunctional drug. CNS Spectr (2009) 0.94
Drug-induced psychosis: how to avoid star gazing in schizophrenia research by looking at more obvious sources of light. Front Behav Neurosci (2011) 0.94
Hallucinations in neurodegenerative diseases. CNS Neurosci Ther (2012) 0.87
LSD flashback syndrome exacerbated by selective serotonin reuptake inhibitor antidepressants in adolescents. J Pediatr (1994) 0.86
Off-label uses of trazodone: a review. Expert Opin Pharmacother (2012) 0.85
Prescribed drugs and neurological complications. J Neurol Neurosurg Psychiatry (2004) 0.85
Visual hallucinations in the differential diagnosis of parkinsonism. J Neurol Neurosurg Psychiatry (2012) 0.82
Sertraline and psychotic symptoms: a case series. Ann Clin Psychiatry (1997) 0.82
Citalopram-induced hallucinations and delusions in a young adult. Gen Hosp Psychiatry (2010) 0.80
Do antidepressants increase the risk of mania and bipolar disorder in people with depression? A retrospective electronic case register cohort study. BMJ Open (2015) 0.80
Hallucination induced by paroxetine discontinuation in patients with major depressive disorders. Psychiatry Clin Neurosci (2011) 0.79
Late-onset schizophrenia: do recent studies support categorizing LOS as a subtype of schizophrenia? Curr Opin Psychiatry (2014) 0.78
Auditory hallucinations: a comparison of beliefs about voices in individuals with schizophrenia and borderline personality disorder. Clin Psychol Psychother (2011) 0.78
New Onset LSD Flashback Syndrome Triggered by the Initiation of SSRIs. Ochsner J (2007) 0.78
Anton syndrome, with vivid visual hallucinations, associated with radiation induced leucoencephalopathy. J Neurol Neurosurg Psychiatry (2009) 0.77
Visual hallucinations during duloxetine treatment in a patient with major depressive disorder. Clin Neuropharmacol (2013) 0.77
Advances in the treatment of visual hallucinations in neurodegenerative diseases. Future Neurol (2013) 0.77
Effects of the antidepressant trazodone, a 5-HT 2A/2C receptor antagonist, on dopamine-dependent behaviors in rats. Psychopharmacology (Berl) (2004) 0.77
Low-dose-trazodone-induced disorganized type psychosis. J Neuropsychiatry Clin Neurosci (2005) 0.76
The role of the retina in visual hallucinations: A review of the literature and implications for psychosis. Neuropsychologia (2017) 0.76
Insomnia and hallucinations in the general population: Findings from the 2000 and 2007 British Psychiatric Morbidity Surveys. Psychiatry Res (2016) 0.75